Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2004
View Archived Issues
SBIR grant for IBD research at Adenosine Therapeutics and U. of Virginia
Read More
Pivotal trial begins for Procleix West Nile virus blood screening assay
Read More
AlzheimAlert test can distinguish vascular cases
Read More
Orally active squalene synthase inhibitors against Trypanosoma cruzi
Read More
Licorice derivative effective against HIV-1
Read More
Suppression of HIV-1 viral replication by p38 MAPK inhibitor
Read More
Fully human anti-ICAM antibody effective in murine psoriasis model
Read More
6R-BH4 reported to decrease serum phenylalanine levels in PKU patients
Read More
PT-141 increases sexual behavior in female rats
Read More
Pharmacokinetic profile of IAalpha5-2 in healthy volunteers
Read More
Significant survival benefit in A-HeFT study of BiDil brings early conclusion
Read More
Plan established with FDA for sBLA filing for Erbitux
Read More
Statistically significant increase in growth rate at six months in SomatoKine study
Read More
Oral bioavailability of alphaHGA demonstrated
Read More
Extension of Neuro3d's research collaboration with Johnson & Johnson
Read More
Roche seeks U.S. and E.U. approval for Pegasys in hepatitis B
Read More
Juvaris BioTherapeutics in collaborative research agreement with Cell Genesys
Read More
Tentative approval for Cipher's CIP-Fenofibrate
Read More
Imvamune receives fast track designation
Read More
Vical's DNA vaccine for anthrax tested in phase I study
Read More
Kahalalide F enters phase II trials in NSCLC and melanoma
Read More
Oxcarbazepine found safe and effective in reducing hypersexuality in male AD patients
Read More
Dronabinol improves agitation in AD patients
Read More
Verbal memory reported to improve with raloxifene in postmenopausal women with AD
Read More
CRF antagonists claimed by Roche
Read More
TGF-beta inhibitors described in patent literature
Read More
Cyclosporins for the treatment of immune disorders
Read More
Antiarrhythmic compound from an Indian snake venom
Read More
Phenylalanine derivatives for the treatment of diabetes claimed by Merck
Read More
Schering claims cannabinoid receptor ligands
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe